{
    "clinical_study": {
        "@rank": "73996", 
        "acronym": "ePAL", 
        "arm_group": [
            {
                "arm_group_label": "Intervention", 
                "arm_group_type": "Experimental", 
                "description": "The intervention group will use the study's mobile application during the 8-week study."
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention", 
                "description": "The control group will not use the study's mobile application during the study."
            }
        ], 
        "brief_summary": {
            "textblock": "The investigators have developed a mobile application (for use on smart phones) to help\n      cancer patients better manage cancer pain. This study is a randomized controlled trial to\n      evaluate the effect of this mobile-based intervention. The investigators' hypothesis is that\n      subjects randomized to the intervention group will achieve greater reductions in\n      cancer-related pain and improved quality of life."
        }, 
        "brief_title": "Pain Management in Cancer Patients Using a Mobile Application", 
        "condition": "Cancer", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All adult patients, 18 years and above suffering from solid-organ cancer.\n\n          -  Diagnosed with moderate or severe cancer pain (i.e. pain intensity score of at least\n             4/10 on numeric rating scale (NRS)) at the Massachusetts General Hospital (MGH)\n             Palliative Care Center, as determined by the patient's care provider at the MGH\n             Palliative Care Center. Subjects do not need to experience a specific nature of pain\n             for eligibility.\n\n          -  Patients must be ambulatory and not currently admitted to the hospital at time of\n             enrollment.\n\n          -  Must have a smart phone and be willing to download the study application (Phase II\n             only)\n\n          -  Must be able to read and speak English.\n\n        Exclusion Criteria:\n\n          -  Life expectancy less than 2-months as determined by the palliative care provider\n\n          -  Significant medical or psychiatric co-morbidities (other than depression or anxiety)\n             or cognitive impediments that would prevent participant from being able to utilize\n             the program\n\n          -  Known history of substance abuse\n\n          -  Patients currently on investigational therapies or other study protocols that may\n             have an impact on pain intensity or quality of life which are main outcomes of this\n             intervention."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "110", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 18, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02069743", 
            "org_study_id": "13-080"
        }, 
        "intervention": {
            "arm_group_label": "Intervention", 
            "description": "A mobile application designed to help cancer patients better self-manage cancer pain.", 
            "intervention_name": "ePAL Mobile Application", 
            "intervention_type": "Other", 
            "other_name": "ePAL"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "cancer pain", 
        "lastchanged_date": "February 20, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02114"
                }, 
                "name": "The Massachusetts General Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Kamal Jethwani, MD, MPH", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Mihir Kamdar, MD", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Stephen Agboola, MD, MPH", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Simone Rinaldi, NP", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Joseph Kvedar, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Pain Management in Cancer Patients Using a Mobile Application", 
        "overall_contact": {
            "email": "CFlanagan2@partners.org", 
            "last_name": "Clare Flanagan, BA", 
            "phone": "617-643-6367"
        }, 
        "overall_contact_backup": {
            "last_name": "Ellen Murachver, MSW", 
            "phone": "617-643-0272"
        }, 
        "overall_official": {
            "affiliation": "Massachusetts General Hospital", 
            "last_name": "Kamal Jethwani, MD, MPH", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary aim is to assess the effect of a tailored, multi-dimensional mobile-based intervention on the intensity of cancer pain in cancer patients with moderate to severe pain.", 
            "measure": "Pain intensity", 
            "safety_issue": "No", 
            "time_frame": "8-weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02069743"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Massachusetts General Hospital", 
            "investigator_full_name": "Kamal Jethwani", 
            "investigator_title": "Corporate Manager - Research & Innovation", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "ESAS-r\nFACT-G", 
                "measure": "Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "4 & 8-weeks"
            }, 
            {
                "description": "In-patient and out-patient hospital visits\nUrgent non-scheduled clinic visits for pain crisis", 
                "measure": "Hospital utilization for pain crisis", 
                "safety_issue": "No", 
                "time_frame": "4 and 8-weeks"
            }, 
            {
                "description": "MMAS-8", 
                "measure": "Adherence to analgesic medications", 
                "safety_issue": "No", 
                "time_frame": "4 & 8-weeks"
            }, 
            {
                "description": "Measured by oral morphine equivalent daily dose", 
                "measure": "Daily opioid consumption", 
                "safety_issue": "No", 
                "time_frame": "4 & 8-weeks"
            }, 
            {
                "description": "BQ-II", 
                "measure": "Perceived barriers to cancer pain management", 
                "safety_issue": "No", 
                "time_frame": "4 & 8-weeks"
            }, 
            {
                "description": "PPQ-K", 
                "measure": "Knowledge of pain management", 
                "safety_issue": "No", 
                "time_frame": "4 & 8-weeks"
            }, 
            {
                "description": "Pattern of patient engagement with the study's mobile application", 
                "measure": "Engagement", 
                "safety_issue": "No", 
                "time_frame": "4 & 8-weeks"
            }
        ], 
        "source": "Massachusetts General Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "The McKesson Foundation", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Massachusetts General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2014", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}